📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MedMira

1.1 - Company Overview

MedMira Logo

MedMira

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of rapid diagnostics, including FDA-approved Reveal G4 for instant HIV results using Rapid Vertical Flow Technology; Multiplo Multiplex Tests for simultaneous detection of HIV-1/2, hepatitis B and C, and syphilis; Reveal HIV; Multiplo TP/HIV; Multiplo HBc/HIV/HCV; and the Miriad RVF Toolkit for developing and commercializing rapid tests.

Products and services

  • Multiplo Multiplex Tests: Multiplex diagnostic products architected for simultaneous detection of HIV-1/2, Hepatitis B, Hepatitis C, and Syphilis
  • Reveal G4: FDA-approved test engineered to deliver instant HIV results using Rapid Vertical Flow Technology, enabling immediate readouts for swift screening workflows
  • Reveal HIV: Rapid test that detects antibodies to HIV-1 and HIV-2 in various testing environments

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MedMira

Calimmune Logo

Calimmune

HQ: United States Website
  • Description: Provider of clinical-stage gene therapies, including a lead gene-based therapeutic candidate engineered to control HIV infection and protect individuals with HIV from progressing to AIDS. The therapy is currently being evaluated in Phase I/II studies. Cal-1 is designed to reduce production of CCR5, a protein.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calimmune company profile →
DDL Logo

DDL

HQ: The Netherlands Website
  • Description: Provider of diagnostic solutions in molecular virology, bioinformatics, molecular bacteriology, and pathology, supporting clinical trials globally across five continents. Offers infectious disease and vaccine development expertise, oncology trial support, rare disease cell and gene therapy operations, biologics and biosimilars services from preclinical to post-market, and customized kit building for sample integrity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DDL company profile →
HilleVax Logo

HilleVax

HQ: United States Website
  • Description: Provider of novel vaccine development and commercialization, focused on HIL-214, a bivalent GI.1/GII.4 virus-like particle (VLP) vaccine candidate in development to prevent moderate-to-severe acute gastroenteritis caused by norovirus infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HilleVax company profile →
Biotest Pharmaceuticals Logo

Biotest Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceutical and biotherapeutic products utilized in immunology, with innovation in haematology, clinical immunology and intensive care medicine, incorporating innovative technologies and a sharp focus on safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biotest Pharmaceuticals company profile →
NanoView Biosciences Logo

NanoView Biosciences

HQ: United States Website
  • Description: Provider of proprietary products supporting research, translation and delivery of precision medicine, built on a novel platform that uniquely identifies and characterizes exosomes. Offers high-throughput, cost-effective analysis, including Leprechaun for lentivirus and exosome biophysical characterization, contaminant detection, and concentration measurement using fluorescence and antibody-based methods.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoView Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MedMira

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MedMira

2.2 - Growth funds investing in similar companies to MedMira

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MedMira

4.2 - Public trading comparable groups for MedMira

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MedMira

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MedMira

What does MedMira do?

MedMira is a provider of rapid diagnostics, including FDA-approved Reveal G4 for instant HIV results using Rapid Vertical Flow Technology; Multiplo Multiplex Tests for simultaneous detection of HIV-1/2, hepatitis B and C, and syphilis; Reveal HIV; Multiplo TP/HIV; Multiplo HBc/HIV/HCV; and the Miriad RVF Toolkit for developing and commercializing rapid tests.

Who are MedMira's competitors?

MedMira's competitors and similar companies include Calimmune, DDL, HilleVax, Biotest Pharmaceuticals, and NanoView Biosciences.

Where is MedMira headquartered?

MedMira is headquartered in Canada.

How many employees does MedMira have?

MedMira has 1,000 employees 🔒.

When was MedMira founded?

MedMira was founded in 2010 🔒.

What sector and industry vertical is MedMira in?

MedMira is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MedMira

Who are the top strategic acquirers in MedMira's sector and industry

Top strategic M&A buyers and acquirers in MedMira's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MedMira?

Top strategic M&A buyers groups and sectors for MedMira include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MedMira's sector and industry vertical

Which are the top PE firms investing in MedMira's sector and industry vertical?

Top PE firms investing in MedMira's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MedMira's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MedMira's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MedMira's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MedMira include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MedMira's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MedMira?

The key public trading comparables and valuation benchmarks for MedMira include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MedMira for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MedMira with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MedMira's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MedMira with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MedMira's' sector and industry vertical?

Access recent funding rounds and capital raises in MedMira's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MedMira